These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8493457)

  • 21. Calciotropic hormones and bone markers in the elderly.
    Gallagher JC; Kinyamu HK; Fowler SE; Dawson-Hughes B; Dalsky GP; Sherman SS
    J Bone Miner Res; 1998 Mar; 13(3):475-82. PubMed ID: 9525348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relations between diurnal variations in serum osteocalcin, cortisol, parathyroid hormone, and ionized calcium in normal individuals.
    Nielsen HK; Laurberg P; Brixen K; Mosekilde L
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):391-8. PubMed ID: 2031437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated intact parathyroid hormone is associated with reduced biochemical markers of bone formation and resorption measured in blood in infant piglets receiving oral dexamethasone for 15 days.
    Guo CY; Weiler H; Atkinson SA
    Biol Neonate; 2001; 80(4):295-9. PubMed ID: 11641553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Function of parathyroid glands in kidney transplant patients--diagnostic value of CAP and CIP.
    Spiechowicz U; Kokot F; Wiecek A
    Ann Transplant; 2004; 9(3):33-6. PubMed ID: 15759544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alfacalcidol therapy biphasically modifies the relationship between the plasma levels of intact PTH and osteocalcin in dialysis patients.
    Kazama JJ; Takamiya H
    Nephron; 1998; 79(3):348-9. PubMed ID: 9678439
    [No Abstract]   [Full Text] [Related]  

  • 27. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypomagnesemia with increased metabolism of parathyroid hormone and reduced responsiveness to calcitropic hormones.
    Mori S; Harada S; Okazaki R; Inoue D; Matsumoto T; Ogata E
    Intern Med; 1992 Jun; 31(6):820-4. PubMed ID: 1392187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of PTH assay methodology on differential diagnosis of renal bone disease.
    Reichel H; Esser A; Roth HJ; Schmidt-Gayk H
    Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effects of histamine H2-receptor antagonists on serum parathyroid hormone in chronic renal failure.
    Fiore CE; Lunetta M; Kanis JA
    Clin Endocrinol (Oxf); 1985 Sep; 23(3):277-82. PubMed ID: 3878237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive correlation of serum bio-intact PTH(1-84) but not intact PTH with parathyroid gland size in hemodialysis patients.
    Inaba M; Okuno S; Chou H; Imanishi Y; Ueda M; Yamakawa T; Ishimura E; Nishizawa Y
    Biomed Pharmacother; 2006 Feb; 60(2):62-5. PubMed ID: 16460905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of relationship between parathyroid hormone and 1,25-dihydroxyvitamin D in chronic renal failure.
    Rudnicki M; McNair P; Transbøl I; Nielsen B
    Nephron; 1991; 58(2):144-9. PubMed ID: 1865969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
    Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
    Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Markers of bone formation and resorption in primary and secondary hyperparathyroidism].
    Kosowicz J; Baszko-Błaszyk D; Horst-Sikorska W; Ruszkowska J
    Pol Arch Med Wewn; 1998 Apr; 99(4):287-97. PubMed ID: 9760816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous vitamin D therapy reduces PTH-(1-84)/large C fragments ratio in chronic hemodialysis patients.
    Kihara T; Ichikawa H; Morimoto H; Yano A; Akagi S; Nakao K; Kohmoto H; Wada J; Kumagai I; Makino H
    Nephron Clin Pract; 2004; 98(3):c93-100. PubMed ID: 15528944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients.
    Dumoulin G; Hory B; Nguyen NU; Bresson C; Fournier V; Bouhaddi M; Chalopin JM; Saint-Hillier Y; Regnard J
    Am J Kidney Dis; 1997 May; 29(5):746-53. PubMed ID: 9159310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical significance of PTH (1-84) and PTH (7-84) in patients with predialysis chronic renal failure in relation to bone metabolism markers].
    Tsuchida T; Ishimura E; Hirowatari K; Matsumoto N; Jono S; Miki T; Inaba M; Nishizawa Y
    Clin Calcium; 2005 Sep; 15 Suppl 1():156-60; discussion 160. PubMed ID: 16272650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assay.
    Tsuchida T; Ishimura E; Hirowatari K; Matsumoto N; Imanishi Y; Jono S; Miki T; Inaba M; Nishizawa Y
    Nephron Clin Pract; 2006; 102(3-4):c108-14. PubMed ID: 16286785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mineral metabolism during a hemofiltration session in children.
    Bianchi ML; Bettinelli A; Soldati L; Saccaggi A; Ortolani S; Edefonti A
    Int J Artif Organs; 1986 Jul; 9(4):257-62. PubMed ID: 3781652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease.
    Herberth J; Fahrleitner-Pammer A; Obermayer-Pietsch B; Krisper P; Holzer H; Malluche HH; Dobnig H
    Clin Nephrol; 2006 May; 65(5):328-34. PubMed ID: 16724653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.